US FDA Cited Animal Lab at Musk’s Neuralink for ‘Objectionable Conditions’

SOURCE www.usnews.com
The US FDA cited Elon Musk's Neuralink for 'objectionable conditions' at its animal testing laboratory. While the issues were not severe enough to require regulatory action, the company was urged to address them. Neuralink aims to help patients with paralysis, blindness, and other disorders using brain chip technology.

Key Points

  • FDA cited Neuralink for 'objectionable conditions' at its animal lab
  • Neuralink aims to use brain chip technology to assist patients with disabilities
  • The company was urged to address the identified problems

Pros

  • Neuralink is working on technology to help patients with various disorders
  • FDA's inspection did not find violations that would undermine the device's safety

Cons

  • Issues of 'objectionable conditions' were found at Neuralink's animal testing facilities